ORCID
- Sube Banerjee: 0000-0002-8083-7649
- Nicolas Farina: 0000-0002-0635-2547
DOI Link
DOI
10.3310/vpdt7105
Publication Date
2023-01-01
Embargo Period
2024-05-09
Recommended Citation
Banerjee, S., Farina, N., Henderson, C., High, J., Stirling, S., Shepstone, L., Fountain, J., Ballard, C., Bentham, P., Burns, A., Fox, C., Francis, P., Howard, R., Knapp, M., Leroi, I., Livingston, G., Nilforooshan, R., Nurock, S., O’brien, J., Price, A., Thomas, A., Swart, A., Telling, T., & Tabet, N. (2023) 'A pragmatic, multicentre, double-blind, placebo-controlled randomised trial to assess the safety, clinical and cost-effectiveness of mirtazapine and carbamazepine in people with Alzheimer’s disease and agitated behaviours: the HTA-SYMBAD trial', Available at: 10.3310/vpdt7105
